Whan In Pharm Co.,Ltd.

KSE 016580.KS

Whan In Pharm Co.,Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 9.64%

Whan In Pharm Co.,Ltd. Return on Capital Employed (ROCE) is 9.64% for the year ending December 31, 2023, a 8.22% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Whan In Pharm Co.,Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 8.90%, a -15.59% change year over year.
Whan In Pharm Co.,Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 10.55%, a 12.40% change year over year.
Whan In Pharm Co.,Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 9.38%, a -6.92% change year over year.
Whan In Pharm Co.,Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 10.08%, a -9.22% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

KSE: 016580.KS

Whan In Pharm Co.,Ltd.

CEO	Mr. Wonbum Lee
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	Whanin Building, 11
Employees	582
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Whan In Pharm Co.,Ltd., a pharmaceutical company, develops, manufactures, markets, and sells therapeutic products in South Korea. It offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years